Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Antiemetic Regimen for PONV in Breast Surgery
NCT00738621Phase 4Completed
- Sponsor
- Baylor Scott & White Health
- Start
- Jul 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Baylor Scott & White Health. Primary endpoint: Incidence of Vomiting during the first 24 hours. Started Jul 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00738621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738621.